Archive for the ‘Health’ Category

Older Entries
Newer Entries

Sculptra: PRODUCT DESCRIPTION AND PHARMACOKINETICS

2, May 2010

Sculptra™ is an injectable implant that contains microparticles of poly-L-lactic acid (PLLA). It is a biodegradable, biocompatible, and immunologically inert synthetic polymer derived from the alpha-hydroxy acid family.

Sculptra

1, May 2010

INTRODUCTION Human immunodeficiency virus (HIV) infection affects approximately one million persons in the U.S. alone. Along with recent advances in HIV treatment options, especially over the past decade, dramatic reductions in HIV-associated morbidity and mortality have been observed. As a result of an increase in life expectancy, however, the severity of side effects from these [...]

European Society of Cardiology: Fish Oil (Omega-3 Polyunsaturated Fatty Acids)

17, Apr 2010

Brouwer IA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) (Abstract 1336) The SOFA trial examined whether fish oil affected arrhythmias in patients with an implantable cardioverter defibrillator (ICD). The intake of very-long-chain omega-3 polyunsaturated fatty acids (PUFAs), found mainly in fish oil, has been thought to reduce the risk of sudden death, possibly [...]

European Society of Cardiology: Enoxaparin and Unfractionated Heparin

16, Apr 2010

Montalescot G: SafeTy and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: An InternationaL Randomized Evaluation (STEEPLE) (Abstract 2574) A bright but still indirect light was thrown on the subject of enoxaparin dosing by a later Hot Line session. The STEEPLE trial compared enoxaparin and UFH in patients undergoing elective PCI. The important difference [...]

European Society of Cardiology

15, Apr 2010

SELECTED SESSIONS Aspirin Serebruany VL: The risk of bleeding complications after different doses of aspirin (ASA): A post-hoc analysis of 192,036patients enrolled in 31 randomized controlled trials (Abstract P3506) A meta-analysis of 31 randomized trials enrolling 192,000 patients was performed to examine the effect of aspirin doses on bleeding. It was found that low daily [...]

American Heart Association: Nesiritide Reduces Mortality Risk in Heart Failure

14, Apr 2010

Speaker: Uri Elkayam, MD, Professor, and Director, Heart Failure Program, Los Angeles County University of Southern California Medical Center, Los Angeles, California Nesiritide (Natrecor, Scios), a recombinant form of human B-type natriuretic peptide (BNP), may diminish the increased acute mortality risk associated with worsening renal function in patients with chronic decompensated heart failure.

American Heart Association: Superior Outcomes in STEMI after Low-Molecular-Weight Heparin

13, Apr 2010

Speaker: Marc S. Sabatine, MD, Associate Physician, Cardiovascular Division, Brigham & Women’s Hospital, and Instructor in Medicine, Harvard Medical School, Boston, Massachusetts The use of a low-molecular-weight heparin (LMWH) plus other standard therapies, including aspirin and clopidogrel (Plavix) may be associated with improved angiographic outcomes, lower rates of major adverse cardiovascular events, and an absence [...]

Pages: Prev 1 2 3 4 5 6 7 8 9 10 ...12 13 14 Next

Older Entries
Newer Entries
top